Dear Editor,
The clinical presentation of dengue fever may vary from minimal symptoms to high fever,
joint and muscle pain, headache and skin rashes, and even to hemorrhagic or shock
syndromes. Neurological manifestations of this disease may come as a result of direct
dengue virus invasion in the central nervous system (CNS)[1], and/or as neuroimmunological syndromes affecting either the CNS or the peripheral
nerves[2]. There is a paucity of data on cases like these, particularly regarding the discussion
on therapy and prognosis. The present study reports on a series of 10 patients with
Guillain-Barré syndrome (GBS) in association with dengue fever in Brazil and discusses
therapeutic approaches and prognostic data on these cases. The study was approved
by the Ethics Committee of Universidade Metropolitana de Santos. Data on patients
with GBS in association with dengue fever were collected by neurologists from seven
different Brazilian institutions in areas where dengue fever is epidemic. Only cases
with complete data were included in this series.
The data on 10 patients with GBS in association with dengue fever are summarized in
the [Table]. The clinical manifestations were variable and often severe, but recovery was mostly
complete and fast. Acute motor sensory axonal neuropathy was identified in all cases.
All the patients were treated with a five-day pulse of immunoglobulin and responded
well. However, full recovery took a variable amount of time, ranging from nine days
to one year.
Table
Data on patients with Guillain-Barré syndrome in association with dengue fever. All
the patients had positive serum tests for dengue fever, electroneuromyography showing
inflammatory peripheral polyneuropathy, and cerebrospinal fluid with protein-cell
dissociation. Serum tests were negative for Zika virus and chikungunya virus.
Case
|
Gender
|
Age
|
Ethnic origin*
|
Days between DF and GBS
|
Neurological manifestations
|
Treatment
|
Clinical outcome
|
1
|
F
|
40
|
white
|
10
|
Dysphonia, dysphagia, bilateral facial nerve paralysis, tetraparesis, paresthesia,
areflexia
|
Immunoglobulin
|
Fully recovered after 6 months
|
2
|
F
|
42
|
white
|
5
|
Tetraparesthesia
|
Immunoglobulin
|
Fully recovered after 4 months
|
3
|
M
|
50
|
white
|
10
|
Paraparesis, paresthesia
|
Immunoglobulin
|
Fully recovered after 1 month
|
4
|
M
|
17
|
black
|
14
|
Tetraparesis
|
Immunoglobulin
|
Fully recovered after 3 months
|
5
|
M
|
29
|
white
|
12
|
Tetraparesis
|
Immunoglobulin
|
Fully recovered after 3 months
|
6
|
F
|
25
|
white
|
7
|
Tetraparesis
|
Immunoglobulin
|
Fully recovered after 2 months
|
7
|
M
|
40
|
black
|
12
|
Dysphagia, bilateral facial nerve paralysis, tetraparesis, areflexia
|
Immunoglobulin
|
Fully recovered after 25 days
|
8
|
M
|
37
|
black
|
15
|
Paraparesis, paresthesia
|
Immunoglobulin
|
Fully recovered after 9 days
|
9
|
M
|
16
|
black
|
14
|
Tetraparesis, areflexia
|
Immunoglobulin
|
Fully recovered
|
10
|
F
|
24
|
white
|
10
|
Tetraparesis, tetraparesthesia
|
Immunoglobulin
|
Fully recovered after 12 months
|
DF = dengue fever; GBS = Guillain-Barré syndrome; *Ethnic origin: white and black
as declared by the patient.
We highlight that GBS in association with dengue fever is a rare condition, with less
than 20 cases described in detail in the literature. A recent report on three cases
in New Caledonia showed findings similar to those reported here[3], while fatal cases have recently been described in India[4] and Pakistan[5]. In Brazil, which has been an endemic region for dengue fever for over two decades,
very few cases of associated GBS have been reported[6],[7],[8],[9]. These authors believe that GBS in association with dengue fever may be underdiagnosed,
even in endemic areas. It is a relatively benign condition that can successfully be
treated with pulses of immunoglobulin if diagnosed early.